DRMAW (DRMAW) Stock Price & Analysis
DRMAW (DRMAW) fell 50.00% to USD 0 as of September 9, 2026 at 13:24 UTC, according to Nexqual real-time market data.
DRMAW last closed at USD 0; the session ranged USD 0–0 on volume of 146,059 shares. Market capitalization is —, with a 52-week range of USD 0–0 (NCM). Source: Nexqual, September 9, 2026 at 13:24 UTC.
Key Statistics (as of September 9, 2026 at 13:24 UTC)
| Price | USD 0 |
|---|---|
| Change | ▼ 50.00% (down) |
| Previous Close | USD 0 |
| Open | USD 0 |
| Day Range | USD 0 – 0 |
| 52-Week Range | USD 0 – 0 |
| Volume | 146,059 shares |
| Market Cap | — |
| Exchange | NCM |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| KTTAW | Pasithea Therapeutics Corp. Warrant | USD 0.01 | ▲ 0% |
| CELUW | Celularity Inc. | USD 0 | ▲ 0% |
| DRTSW | Alpha Tau Medical Ltd. Warrant | USD 4.23 | ▲ 1.37% |
| JSPRW | Jasper Therapeutics, Inc. | USD 0.01 | ▼ 19.57% |
| CINGW | Cingulate Inc. Warrants | USD 0.01 | ▼ 35.4% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 9, 2026 at 13:24 UTC. This page is informational and not investment advice.